Marshall Wace’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$347K Sell
23,931
-63,257
-73% -$734K ﹤0.01% 2599
2025
Q4
$838K Buy
87,188
+13,464
+18% +$129K ﹤0.01% 2019
2025
Q3
$693K Buy
73,724
+50,942
+224% +$486K ﹤0.01% 2105
2025
Q2
$241K Buy
+22,782
New +$287K ﹤0.01% 2398
2025
Q1
Sell
-10,426
Closed -$172K 2605
2024
Q4
$172K Sell
10,426
-5,955
-36% -$117K ﹤0.01% 2380
2024
Q3
$405K Sell
16,381
-11,433
-41% -$296K ﹤0.01% 1997
2024
Q2
$705K Sell
27,814
-6,478
-19% -$168K ﹤0.01% 1822
2024
Q1
$871K Buy
34,292
+13,720
+67% +$332K ﹤0.01% 1709
2023
Q4
$466K Buy
+20,572
New +$426K ﹤0.01% 1742
2023
Q1
Sell
-15,845
Closed -$469K 2623
2022
Q4
$469K Buy
+15,845
New +$451K ﹤0.01% 2403
2022
Q3
Sell
-46,343
Closed -$1.03M 3304
2022
Q2
$1.03M Buy
+46,343
New +$1.03M ﹤0.01% 2423
2021
Q4
Sell
-9,536
Closed -$406K 3834
2021
Q3
$406K Buy
+9,536
New +$393K ﹤0.01% 2498
2021
Q2
Sell
-13,383
Closed -$546K 2619
2021
Q1
$546K Buy
+13,383
New +$508K ﹤0.01% 1904
2020
Q2
Sell
-6,177
Closed -$179K 1517
2020
Q1
$179K Buy
+6,177
New +$250K ﹤0.01% 1201
2019
Q3
Sell
-21,040
Closed -$855K 1655
2019
Q2
$855K Sell
21,040
-34,970
-62% -$1.28M 0.01% 974
2019
Q1
$1.69M Sell
56,010
-78,323
-58% -$2.68M 0.02% 794
2018
Q4
$4.51M Buy
+134,333
New +$4.85M 0.05% 476
2016
Q2
Sell
-19,081
Closed -$853K 977
2016
Q1
$853K Buy
19,081
+3,940
+26% +$160K 0.01% 750
2015
Q4
$578K Buy
+15,141
New +$579K 0.01% 785
2015
Q3
Sell
-9,413
Closed -$311K 901
2015
Q2
$311K Buy
+9,413
New +$336K ﹤0.01% 769
2015
Q1
Sell
-48,281
Closed -$1.97M 788
2014
Q4
$1.97M Sell
48,281
-24,852
-34% -$971K 0.03% 463
2014
Q3
$2.68M Buy
+73,133
New +$3.16M 0.04% 392

Other funds holding ANIK